1120264

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

February 27, 2020

Fiscal Year

2020

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

New York, NY (United States)

Additional Details